Praxis Precision Medicines (PRAX) Shares Outstanding (2019 - 2026)

Praxis Precision Medicines' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $27.9 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 36.96% year-over-year to $27.9 million in Q1 2026; TTM through Mar 2026 was $27.9 million, a 36.96% increase from a year earlier, with the FY2025 full-year figure at $25.2 million, up 29.72% from the prior year.
• Shares Outstanding (Entity) rose to $27.9 million in Q1 2026 per PRAX's latest filing, from $25.2 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $27.9 million in Q1 2026 and bottomed at $3.0 million in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $13.3 million (2024), against an average of $12.9 million.
• Across the five-year window, Shares Outstanding (Entity) grew 1.97% in 2022 and jumped 281.87% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $3.3 million in 2022, then jumped by 100.29% to $6.6 million in 2023, then jumped by 194.53% to $19.4 million in 2024, then advanced by 29.72% to $25.2 million in 2025, then grew by 10.58% to $27.9 million in 2026.
• Per Business Quant, the three latest PRAX Shares Outstanding (Entity) figures stand at $27.9 million (Q1 2026), $25.2 million (Q4 2025), and $21.2 million (Q3 2025).